926905-71-7 Usage
General Description
N-Acetyl-4-hydroxy-L-proline is a mixture of the cis and trans isomers of a chemical compound that is derived from the amino acid proline. It is commonly used in skincare and cosmetic products due to its moisturizing and anti-aging properties. N-Acetyl-4-hydroxy-L-proline (cis- and trans- Mixture) is known to help improve the skin's elasticity, promote collagen synthesis, and reduce the appearance of fine lines and wrinkles. Additionally, it has antioxidant properties that can help protect the skin from damage caused by free radicals. The combination of both cis and trans isomers in this mixture provides enhanced effectiveness in promoting skin health and youthfulness.
Check Digit Verification of cas no
The CAS Registry Mumber 926905-71-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,9,0 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 926905-71:
(8*9)+(7*2)+(6*6)+(5*9)+(4*0)+(3*5)+(2*7)+(1*1)=197
197 % 10 = 7
So 926905-71-7 is a valid CAS Registry Number.
926905-71-7Relevant articles and documents
Aminoacid derivatives of cephalosporin compounds
-
, (2008/06/13)
Novel organic amide compounds which are N-[6-[(acylaminoacylamino or aminoacylamino)phenyl]-1,2-dihydro-2-oxonicotinyl]cephalosporin compounds having broad spectrum antibacterial utility are provided by (a) reacting the free amino acid of the appropriate cephalosporin or the acid salt or silylated derivative or complex thereof with a reactive derivative of the corresponding N-6-[(acylaminoacylamino or aminoacylamino)phenyl]-1,2-dihydro-2-oxonicotinic acid or (b) reacting the free amino acid 7-aminocephalosporanic acid or a related compound or the acid salt or silylated derivative thereof with a reactive derivative of the corresponding D-N-[6-(acylaminoacylamino or aminoacylamino)phenyl]-1,2-dihydro-2-oxonicotinyl]-2-substituted glycine. Pharmaceutical compositions containing said compounds and methods for treating infections using said compositions are also disclosed.
